whi p154 has been researched along with Leukemia in 2 studies
WHI P154: an anti-leukemic agent; structure in first source
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudbeck, EA | 2 |
| Liu, XP | 2 |
| Narla, RK | 1 |
| Mahajan, S | 1 |
| Ghosh, S | 2 |
| Mao, C | 1 |
| Uckun, FM | 2 |
| Zheng, Y | 1 |
| Myers, DE | 1 |
1 review available for whi p154 and Leukemia
| Article | Year |
|---|---|
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De | 2001 |
1 other study available for whi p154 and Leukemia
| Article | Year |
|---|---|
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Computer Simulation; Drug Design; Drug Evaluation, | 1999 |